Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26865261 |
1 | ||
Arthropod bite, Food allergy, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 702 | 26846968 |
CA |
26 | |
Crohn^s disease, Abdominal distension, Lung disorder, Abdominal discomfort, Abdominal pain, Disseminated tuberculosis, Intentional dose omission, Decreased appetite, Condition aggravated, Anal fissure, Harvey-Bradshaw index increased, Weight decreased, Vomiting, Cough, Sputum discoloured, Abdominal pain upper, Nausea, Fatigue, Pain, Pyrexia, Weight increased, Urinary tract infection, Helicobacter infection, Infection, Therapy interrupted, Off label use, Underdose, Therapy partial responder, Therapeutic response shortened, Product availability issue, Inappropriate schedule of product administration, Product dose omission issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 703 | 26847288 |
US |
1 | |
Cardiac flutter, Myalgia, Lethargy, Asthenia, Headache, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 704 | 26847465 |
US |
2 | |
Hospitalisation, Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 705 | 26847543 |
CA |
23 | 2 |
Small intestinal obstruction, Maternal exposure during pregnancy, Nausea, Abdominal pain, Drug level decreased, Incorrect dosage administered, Intentional product use issue, Off label use, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE, |
||||
| 706 | 26847678 |
CA |
34 | |
Intestinal fistula, Symptom recurrence, Weight decreased, Therapy interrupted, Off label use, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, HYDROCORTISONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 707 | 26847709 |
US |
39 | 2 |
Haematuria, Bladder spasm, Dysuria, Pollakiuria, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 708 | 26847798 |
US |
66 | 2 |
Rheumatoid arthritis, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 709 | 26848356 |
US |
32 | 2 |
Rheumatoid arthritis, Psoriatic arthropathy, Therapy interrupted, Osteoarthritis, Psoriasis, |
||||
ETANERCEPT, |
||||
| 710 | 26848386 |
US |
1 | |
Compression fracture, Pain, Hypoacusis, Therapy interrupted, Unevaluable event, |
||||
EVOLOCUMAB, |
||||
| 711 | 26848545 |
US |
1 | |
Psoriatic arthropathy, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 712 | 26848659 |
US |
87 | 2 |
Cerebrovascular accident, Hip surgery, Dementia, Arthropathy, Pain, Gait disturbance, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 713 | 26848942 |
AU |
1 | |
Syncope, Therapy interrupted, |
||||
DAPAGLIFLOZIN, |
||||
| 714 | 26848959 |
US |
53 | 2 |
Therapy interrupted, Product prescribing issue, |
||||
LENALIDOMIDE, |
||||
| 715 | 26849162 |
US |
2 | |
Muscle twitching, Product distribution issue, Stress, Overdose, Seizure, Therapy interrupted, |
||||
BRIVARACETAM, BRIVARACETAM, MIDAZOLAM, MIDAZOLAM, MIDAZOLAM, |
||||
| 716 | 26849235 |
US |
55 | 2 |
Product prescribing issue, Therapy interrupted, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 717 | 26850417 |
CO |
89 | 2 |
Death, Product dispensing issue, Therapy interrupted, |
||||
| 718 | 26850611 |
2 | ||
White blood cell count decreased, Therapy interrupted, |
||||
ASCIMINIB, |
||||
| 719 | 26850661 |
US |
37 | 2 |
Migraine, Dizziness, Facial pain, Therapy interrupted, |
||||
ERENUMAB-AOOE, |
||||
| 720 | 26850736 |
2 | ||
Haemoglobin decreased, Therapy interrupted, |
||||
BELZUTIFAN, |
||||
| 721 | 26850737 |
2 | ||
Therapy interrupted, Adverse drug reaction, |
||||
BELZUTIFAN, |
||||
| 722 | 26850799 |
|||
Therapy interrupted, Myocardial infarction, Cerebrovascular accident, |
||||
ETANERCEPT, |
||||
| 723 | 26850937 |
US |
2 | |
Haemoptysis, Dysphonia, Bronchospasm, Heart rate increased, Anxiety, Lung disorder, Mycobacterium avium complex infection, Frustration tolerance decreased, Cough, Dyspnoea, Oxygen saturation decreased, Illness, Decreased appetite, Bronchiectasis, Hyperkeratosis, Chest discomfort, Dysgeusia, Tooth discolouration, Fatigue, Vaginal haemorrhage, Nausea, Condition aggravated, Drug ineffective, Therapy interrupted, Adverse drug reaction, Unevaluable event, Product dose omission issue, Product package associated injury, Product packaging difficult to open, Product use complaint, Product container issue, Inability to afford medication, Intentional dose omission, Insurance issue, Off label use, |
||||
OMADACYCLINE, AMIKACIN, BRENSOCATIB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, QUERCETIN, QUERCETIN,, AMIKACIN, PRASTERONE, ACETYLCYSTEINE, CLOFAZIMINE, ERGOCALCIFEROL, LINEZOLID, CEFTAZIDIME, MAGNESIUM OXIDE, TEMAZEPAM, |
||||
| 724 | 26851504 |
US |
||
Urticaria, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, |
||||
| 725 | 26851509 |
64 | 1 | |
Blood glucose increased, Ascites, Hypoaesthesia, Anger, Constipation, Oedema peripheral, Sleep disorder, Decreased appetite, Therapy interrupted, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 726 | 26852057 |
US |
2 | |
Hospitalisation, Therapy interrupted, |
||||
TREPROSTINIL, SOTATERCEPT-CSRK, MACITENTAN, |
||||
| 727 | 26854720 |
73 | 1 | |
Pneumonia, Hypoxia, Lactic acidosis, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 728 | 26854756 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
CINACALCET, CINACALCET HYDROCHLORIDE, |
||||
| 729 | 26854765 |
63 | 2 | |
Lactic acidosis, Urosepsis, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 730 | 26854767 |
64 | 2 | |
Upper respiratory tract infection, Therapy interrupted, |
||||
POMALIDOMIDE, ACYCLOVIR, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOBENZAPRINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 731 | 26854817 |
1 | ||
Surgery, Therapy interrupted, |
||||
UPADACITINIB, CETIRIZINE HCL, CETIRIZINE, VENLAFAXINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, LISINOPRIL, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 732 | 26854930 |
82 | 1 | |
Chest pain, Aortitis, Autoimmune disorder, Viral infection, Vascular pseudoaneurysm, Infective aneurysm, Nonspecific reaction, Vasculitis, Therapy interrupted, |
||||
GLOFITAMAB, PIRTOBRUTINIB, OBINUTUZUMAB, |
||||
| 733 | 26854980 |
1 | ||
Nonspecific reaction, Cardiac disorder, Therapy interrupted, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, |
||||
| 734 | 26854982 |
1 | ||
Heart rate irregular, Therapy interrupted, |
||||
TAFAMIDIS, |
||||
| 735 | 26854987 |
1 | ||
Confusional state, Infection, Hypotension, Therapy interrupted, |
||||
TAFAMIDIS, GABAPENTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOCARBAMOL, METHOCARBAMOL TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, REPAGLINIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 736 | 26855377 |
68 | 2 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 737 | 26855446 |
71 | 2 | |
Knee arthroplasty, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 738 | 26856259 |
2 | ||
Pneumonia, Therapy interrupted, |
||||
TEZEPELUMAB-EKKO, |
||||
| 739 | 26856338 |
61 | 2 | |
Therapy interrupted, Influenza, Hand deformity, |
||||
ETANERCEPT, |
||||
| 740 | 26856678 |
70 | 1 | |
Hospitalisation, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 741 | 26861226 |
54 | 2 | |
Heat stroke, Therapy interrupted, Road traffic accident, Pain, |
||||
ABALOPARATIDE, |
||||
| 742 | 26845879 |
US |
46 | |
Therapy interrupted, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 743 | 26845902 |
US |
50 | 1 |
Endocrine ophthalmopathy, Therapy interrupted, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, ATENOLOL, BUPROPION HYDROCHLORIDE, METHIMAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 744 | 26846130 |
US |
59 | 2 |
Rash, Sleep disorder, Rash papular, Rash pruritic, Therapy interrupted, |
||||
| 745 | 26848993 |
55 | 2 | |
Toe amputation, Therapy interrupted, |
||||
BELIMUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, ROSUVASTATIN, INDOMETHACIN, ESCITALOPRAM, LOSARTAN, PREGABALIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 746 | 26845074 |
JP |
80 | |
Fracture, Therapy interrupted, |
||||
DENOSUMAB, ROMOSOZUMAB-AQQG, |
||||
| 747 | 26845099 |
CA |
25 | |
Wisdom teeth removal, Nausea, Sneezing, Swelling, Inappropriate schedule of product administration, Therapeutic response shortened, Product dose omission issue, Intentional dose omission, Inability to afford medication, Therapy interrupted, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, EPINEPHRINE, ADRENALINUM, |
||||
| 748 | 26845361 |
CA |
61 | |
Gastrointestinal surgery, Therapy interrupted, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, |
||||
| 749 | 26845477 |
US |
57 | 2 |
Device difficult to use, Therapy interrupted, Drug ineffective, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, |
||||
| 750 | 26845485 |
CA |
31 | |
Hospitalisation, Therapy interrupted, Intentional product use issue, Product dose omission issue, Drug ineffective, |
||||
INFLIXIMAB-DYYB, |
||||
| 751 | 26851226 |
2 | ||
Dyspnoea, Fluid retention, Pain, Feeling abnormal, Therapy interrupted, |
||||
ERYTHROPOIETIN, ERYTHROPOIETIN, SELEXIPAG, |
||||
| 752 | 26856100 |
55 | 2 | |
Therapy interrupted, Osteoarthritis, Pain, Psoriatic arthropathy, |
||||
UPADACITINIB, |
||||
| 753 | 26839758 |
AE |
2 | |
Unevaluable event, Dyspnoea, Fatigue, Therapy interrupted, Fluid retention, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 754 | 26839795 |
US |
69 | |
Urinary retention, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, |
||||
| 755 | 26839892 |
US |
2 | |
Therapy interrupted, |
||||
ROPEGINTERFERON ALFA-2B, |
||||
| 756 | 26839935 |
US |
63 | 1 |
Parkinson^s disease, Freezing phenomenon, Loss of personal independence in daily activities, Gait disturbance, Tremor, Nausea, Drug effect less than expected, Therapy interrupted, Product use issue, Therapy cessation, |
||||
CARBIDOPA, CARBIDOPA TABLETS, LEVODOPA, PRAMIPEXOLE, ENTACAPONE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SERTRALINE, HYDROXYZINE PAMOATE, |
||||
| 757 | 26839953 |
US |
57 | 1 |
Off label use, Therapy interrupted, Product distribution issue, Adverse drug reaction, Product prescribing issue, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 758 | 26840006 |
US |
2 | |
Psoriatic arthropathy, Psoriasis, Therapy interrupted, Intentional product misuse, |
||||
APREMILAST, |
||||
| 759 | 26840062 |
US |
34 | 1 |
Hospitalisation, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 760 | 26840649 |
US |
59 | 2 |
Rheumatoid arthritis, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 761 | 26840728 |
US |
84 | 2 |
Therapy interrupted, Insurance issue, Full blood count decreased, |
||||
LENALIDOMIDE, |
||||
| 762 | 26840848 |
US |
61 | 2 |
Therapy interrupted, Illness, Pain, Electric shock sensation, Malaise, Therapy change, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, AMLODIPINE BESYLATE, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 763 | 26841994 |
GB |
72 | |
Crohn^s disease, Product distribution issue, Therapy interrupted, Product prescribing issue, |
||||
USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, |
||||
| 764 | 26842291 |
US |
53 | |
Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 765 | 26842364 |
US |
73 | |
Inability to afford medication, Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 766 | 26843452 |
1 | ||
Localised infection, Staphylococcal infection, Therapy interrupted, |
||||
CAPECITABINE, |
||||
| 767 | 26843626 |
2 | ||
Staphylococcal infection, Pneumonia bacterial, Therapy interrupted, |
||||
CAPMATINIB, |
||||
| 768 | 26844421 |
US |
59 | 2 |
Diarrhoea, Electrolyte imbalance, Product distribution issue, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 769 | 26844678 |
GB |
35 | 2 |
Psoriatic arthropathy, Therapy interrupted, Product temperature excursion issue, Product storage error, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 770 | 26844704 |
US |
62 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 771 | 26844740 |
US |
60 | 2 |
Psoriatic arthropathy, Loss of personal independence in daily activities, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 772 | 26844857 |
US |
43 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 773 | 26844914 |
US |
63 | |
Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 774 | 26849387 |
46 | 2 | |
Product distribution issue, Therapy interrupted, |
||||
LEVETIRACETAM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 775 | 26849434 |
|||
Therapy interrupted, Pulmonary oedema, Chest pain, Pulmonary mass, Neoplasm malignant, |
||||
TADALAFIL, MACITENTAN, |
||||
| 776 | 26851453 |
61 | 1 | |
Colitis, Colitis, Diarrhoea, Therapy interrupted, Clostridium difficile infection, |
||||
NIVOLUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 777 | 26855577 |
1 | ||
Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 778 | 26855578 |
77 | 1 | |
Cerebrovascular accident, Therapy interrupted, Diarrhoea, Vomiting, Weight decreased, |
||||
NINTEDANIB, |
||||
| 779 | 26855581 |
61 | 1 | |
Therapy interrupted, Imprisonment, Joint swelling, |
||||
ETANERCEPT, |
||||
| 780 | 26855663 |
31 | 2 | |
Therapy interrupted, Migraine with aura, |
||||
ETANERCEPT, |
||||
| 781 | 26834589 |
US |
46 | 1 |
Dyspnoea exertional, Dizziness postural, Asthenia, Nausea, Dyspnoea, Product use issue, Therapy interrupted, Therapy non-responder, Product administration interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CHLORTHALIDONE, LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, MACITENTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 782 | 26835062 |
US |
68 | 2 |
Withdrawal syndrome, Malaise, Therapy interrupted, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 783 | 26835281 |
US |
63 | 2 |
Inflammation, Joint swelling, Abdominal discomfort, Therapy interrupted, Mobility decreased, Drug dose omission by device, Pain, Diarrhoea, |
||||
ETANERCEPT, ETANERCEPT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 784 | 26835335 |
US |
79 | 2 |
Psoriatic arthropathy, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 785 | 26835987 |
US |
1 | |
General physical health deterioration, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 786 | 26836062 |
US |
14 | |
Needle issue, Therapy interrupted, Product supply issue, Intentional product use issue, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 787 | 26836378 |
US |
84 | 2 |
Therapy interrupted, Product supply issue, Inappropriate schedule of product administration, |
||||
POMALIDOMIDE, |
||||
| 788 | 26836762 |
US |
76 | 1 |
Femur fracture, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 789 | 26836991 |
IN |
68 | 2 |
Spinal fracture, Rebound effect, Intentional product misuse, Therapy interrupted, |
||||
DENOSUMAB, |
||||
| 790 | 26837304 |
US |
60 | 2 |
Dementia Alzheimer^s type, Therapy interrupted, |
||||
PLECANATIDE, |
||||
| 791 | 26837580 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 792 | 26838053 |
US |
46 | 2 |
Dry eye, Foreign body sensation in eyes, Product use issue, Therapy interrupted, Intentional product use issue, Product packaging quantity issue, Product supply issue, |
||||
PERFLUOROHEXYLOCTANE, |
||||
| 793 | 26838131 |
US |
72 | 1 |
Therapy interrupted, Product prescribing issue, Back pain, |
||||
POMALIDOMIDE, |
||||
| 794 | 26838439 |
US |
11 | 1 |
Underdose, Product use issue, Therapy interrupted, No adverse event, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 795 | 26838653 |
CA |
74 | 2 |
Death, Blood pressure abnormal, Haemorrhage, Diarrhoea, Product dose omission issue, Gait disturbance, Dermatitis diaper, Malaise, Gastrointestinal disorder, Therapy interrupted, |
||||
APIXABAN, FUROSEMIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PANTOPRAZOLE, IBRUTINIB, |
||||
| 796 | 26838775 |
US |
26 | 2 |
Petit mal epilepsy, Therapy interrupted, Product availability issue, Overdose, |
||||
LACOSAMIDE, |
||||
| 797 | 26839335 |
US |
66 | 2 |
Accidental exposure to product, Exposure via skin contact, Therapy interrupted, Blood cholesterol increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 798 | 26842120 |
2 | ||
Pyrexia, Diarrhoea, Therapy interrupted, |
||||
IMATINIB MESYLATE, IMATINIB, |
||||
| 799 | 26842165 |
2 | ||
Gastrointestinal disorder, Blood bilirubin increased, Therapy interrupted, |
||||
RIBOCICLIB, |
||||
| 800 | 26842167 |
1 | ||
Pruritus, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30